What we know about;

CSL Behring Türkiye

We are a global biotechnology leader focused on meeting the needs of patients. Our innovative drug portfolio includes various recombinant and plasma-derived products for the treatment of bleeding disorders, immune deficiencies, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema, and Alpha-1 antitrypsin deficiency. Our mission is to discover, develop, and deliver innovative therapies that improve the quality of life for patients.